Market Notices: Market Notice 83/22– Last day of trading in Hamlet Pharma AB’s subscription option HAMLET TO 3 B

Reports: Hamlet Pharma Q3 Interim Report  January – March 2022

Press release from Companies: Newsletter  -  Recent Presentations of Hamlet Pharma

Press release from Companies: Teckningskurs för utnyttjandet av teckningsoptioner av serie TO 3 B i Hamlet Pharma AB (publ) har fastställts till 3.28 SEK per aktie

Press release from Companies: Martin Erixon joins Hamlet Pharma as new CEO

Press release from Companies: Successful review of HAMLET Pharma by the EU Horizon 2020 program

Press release from Companies: Hamlet Pharma presenterar på Stockholm Corporate Finance 14e Life Science Kapitalmarknadsdagar

Reports: Hamlet Pharma AB Interim Report Q2; October – December 2021

Press release from Companies: Hamlet NEWSLETTER Important steps forward towards treating bladder cancer

Press release from Companies: Successful completion of the dose escalation study in patients with bladder cancer

Press release from Companies: NEW STRATEGIC RECRUITS TO HAMLET PHARMA

Press release from Companies: Hamlet Pharma focuses on communication